PMID: 9194036Jan 1, 1997Paper

An ATP bioluminescence assay applicable to rapid fluconazole susceptibility testing of dermatophytes

Microbiology and Immunology
T YoshidaHideyo Yamaguchi

Abstract

An ATP bioluminescence assay as a rapid reference method for fluconazole (FLCZ) susceptibility testing of dermatophytes, as well as yeasts, was developed and evaluated by comparing it with viability, turbidity and fungal protein content-based conventional methods. FLCZ susceptibility results obtained with strains of Candida albicans and dermatophytes by the bioluminescence method in high-resolution medium were well correlated with those obtained by conventional methods currently used in clinical microbiology laboratories or reported previously, including a broth dilution method by the National Committee for Clinical Laboratory Standards (NCCLS). Thus, ATP bioluminescence assay can be used to monitor fungal growth in liquid culture media. The procedure has considerable potential for the rapid testing of FLCZ susceptibility of dermatophytes and other fungi.

References

Mar 1, 1979·Sabouraudia·A Shiraishi, T Arai
Dec 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Wüst, U Hardegger
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·M A PfallerD W Warnock
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M G Rinaldi
Aug 1, 1991·Journal of Medical Microbiology·D I LimbR C Spencer
Mar 1, 1990·Reviews of Infectious Diseases·P F TrokeK Richardson
Sep 1, 1990·Antimicrobial Agents and Chemotherapy·M A PfallerF C Odds
Sep 1, 1989·Journal of Surgical Oncology·Y YonemuraI Miyazaki
Sep 1, 1988·Journal of Clinical Microbiology·M A GordonP G Passero
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·L E NilssonS Anséhn
Feb 1, 1988·Journal of Medical Microbiology·P F WheatR C Spencer
Dec 1, 1985·European Journal of Clinical Microbiology·B BeckersA Lammers
Oct 1, 1972·The Journal of Infectious Diseases·P D Hoeprich, P D Finn
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·R C CookseyJ T Crawford
Oct 1, 1993·Clinical Microbiology Reviews·J H RexJ N Galgiani
May 1, 1993·Journal of Clinical Pathology·D I LimbB Watt
Jan 1, 1993·Antimicrobial Agents and Chemotherapy·R A FromtlingG D Roberts
Jul 1, 1996·Diagnostic Microbiology and Infectious Disease·M KretschmarH Hof

❮ Previous
Next ❯

Citations

Jul 18, 2015·Journal of Microbiological Methods·Khalida RiziSanjib Bhakta
Mar 5, 2016·Medical Mycology Journal·Tsuyoshi ShimamuraNobuo Kubota
Feb 5, 2021·Transactions of the Royal Society of Tropical Medicine and Hygiene·Wendy W J van de Sande

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.